Funded Tech Companies
Neurophth Therapeutics
Headquartered in Wuhan Hubei Province, Neurophth Therapeutics is venture-backed, with investment from Guangzhou Jinkong Fund, Wuhan Optical Valley Health and Wuhan Hi-Tech Holding Group.
Company Overview
Company Name
Neurophth Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3rd Floor Building B1 Optics Valley Biological City No.666 G C270-C271
Wuhan Hubei Province, Undisclosed
China
Wuhan Hubei Province, Undisclosed
China
Phone
Website
Email Address
Company Background Information
Overview
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/11/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Li Bin
Chief Executive Officer
Alvin Luk
Chief Financial Officer
Su Zhang
Chief Operating Officer
Xin Zhang
Chief Scientific Officer
Qiutang Li
Chief Technical Officer
Bose Kalampanayil
Co-Founder
Dabo Cai
General Manager
Su Xiao
Vice President
Luke Li
VP - Human Resources
Jane Yang
VP - Regulatory Affairs
Cao Yang
Company Investors
- Guangzhou Jinkong Fund
- Wuhan Optical Valley Health
- Wuhan Hi-Tech Holding Group
- Zhejiang Silicon Paradise Asset Management
- Yangtze River Industry Fund
- CMB International Capital Corporation
- Hubei KTLC
- SDIC Fund Management
- Sunshine Insurance
- China Merchants Venture Capital
- Sequoia Capital (Trency Gu)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs